16874-73-0 Usage
Uses
Used in Pharmaceutical Industry:
(R,S)-4-(1-hydroxyethyl)oxazolidine-2,5-dione is used as a precursor in the synthesis of various pharmaceuticals and chiral catalysts due to its unique structure and reactivity.
Used in Chelating Agents:
In the pharmaceutical industry, (R,S)-4-(1-hydroxyethyl)oxazolidine-2,5-dione is used as a building block for chelating agents, which are essential in various chemical and biological processes.
Used in Asymmetric Catalysis:
(R,S)-4-(1-hydroxyethyl)oxazolidine-2,5-dione is also utilized in asymmetric catalytic processes, which are crucial for the selective synthesis of enantiomerically pure compounds, a significant aspect in drug development.
Used in Antitumor and Antiviral Research:
(R,S)-4-(1-hydroxyethyl)oxazolidine-2,5-dione is being investigated for its potential antitumor and antiviral activities, which could lead to the development of new therapeutic agents for cancer and viral infections.
Used in Drug Development:
The chiral nature of (R,S)-4-(1-hydroxyethyl)oxazolidine-2,5-dione makes it a versatile building block for the development of new drugs and materials, contributing to the advancement of pharmaceutical research and innovation.
Check Digit Verification of cas no
The CAS Registry Mumber 16874-73-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,8,7 and 4 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 16874-73:
(7*1)+(6*6)+(5*8)+(4*7)+(3*4)+(2*7)+(1*3)=140
140 % 10 = 0
So 16874-73-0 is a valid CAS Registry Number.
InChI:InChI=1/C5H7NO4/c1-2(7)3-4(8)10-5(9)6-3/h2-3,7H,1H3,(H,6,9)
16874-73-0Relevant academic research and scientific papers
ENANTIOMERIC QUANTIFICATIONS OF AMINO ACIDS THROUGH THEIR Nα-ACYL AMIDES BY GAS CHROMATOGRAPHY.
Hosten, N.,Anteunis, M. J. O.
, p. 45 - 47 (2007/10/02)
Apparent separation of 1.1 or higher on Chiralsil Val III can be obtained for Nα-acyl N-alkyl aminoacid amides allowing the use of short capillary gas chromatographic columns.A clean derivatization protocol without racemization is described, proceding through the NCA derivatives that are prepared from "in situ" silylated amino acids with trimethylsilyl cyanide.
